The START Center for Cancer Care Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2007
NCT00881166
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Director of Clinical Research START Midwest

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 13